Home
Institutions
Filings
Issuers
About
All
Index / Passive
Hedge Fund
VC / PE / Holdco
Long-Term Concentrated
Concentrated Active
Quant / Systematic
Diversified Active
THERAVANCE BIOPHARMA INC
Ticker: TBPH
CUSIP: G8807B106
Class: Common Stock
JAMES INVESTMENT RESEARCH INC's Holding History (CIK: 0000810384)
Note: Option positions (PUT/CALL) are excluded.
Q4 2025
Shares
14,833
Value ($000)
$278
Avg Close
$16.59
Range
$13.50 - $20.33
Period
Shares
Value ($000)
Average Close
Price Range
Q4 2025
14,833
$278
$16.59
$13.50 - $20.33